{"ORPHApacket":[{"ORPHApacketID":"163921","date":"2019-12-05 23:02:05","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"163921","Name":[{"lang":"en","label":"Posttransplant acute limbic encephalitis"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_163921","DisorderType":[{"Name":[{"lang":"en","label":"Particular clinical situation in a disease or syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377793"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Non-paraneoplastic limbic encephalitis"}],"ORPHA":"163918","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_163918"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Posttransplant acute limbic encephalitis is a rare, acquired, non-paraneoplastic limbic encephalitis disorder, that develops in the setting of treatment-related immunosuppression, typically after allogeneic hemapoietic stem cell transplantation, characterized by onset of confusion, headache, anterograde amnesia, seizures and\/or loss of consciousness 2-6 weeks following transplantation. Bilateral, non-enhancing T2 hyperintensities in limbic structures are observed on magnetic resonance imaging. Mild cerebrospinal fluid pleocytosis and syndrome of inappropriate antidiuretic hormone secretion may also be associated."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"All ages"}]}]}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"PALE"}]}]}]}